Evidence map›Paper›PMID 30909391›Full record

ReviewMicroorganisms2019

Rose C Lopeman, James Harrison, Maya Desai, Jonathan A G Cox

Open access · goldAbstract readReview
In one paragraph

Review in Microorganisms, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 113 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed, 1 pooled it
12.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 1 synthesis or guideline pooled it, 163 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Leucine auxotrophic marker for genetic manipulation ofApplied and environmental microbiology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. PD-1 deficiency exacerbatesFrontiers in immunology · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Article

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Rose C LopemanSchool of Life and Health Sciences, Aston University, Aston Triangle, Birmingham B4 7ET, UK. lopemarc@aston.ac.uk.
James HarrisonSchool of Life and Health Sciences, Aston University, Aston Triangle, Birmingham B4 7ET, UK. j.harrison11@aston.ac.uk.
Maya DesaiBirmingham Children's Hospital, Birmingham Women's and Children's NHS Foundation Trust, Steelhouse Lane, Birmingham B4 6NH, UK. maya.desai@nhs.net.
Jonathan A G CoxSchool of Life and Health Sciences, Aston University, Aston Triangle, Birmingham B4 7ET, UK. J.a.g.cox@aston.ac.uk.ORCID 0000-0001-5208-4056
Aston University · GBBirmingham Children's Hospital · GB

Funding

Academy of Medical Sciences (SBF003\1088:)Birmingham Women's and Children's Hospital Charity Research Foundation 50% PhD Studentship
6 · The paper itself

Abstract

Mycobacteria are a large family of over 100 species, most of which do not cause diseases in humans. The majority of the mycobacterial species are referred to as nontuberculous mycobacteria (NTM), meaning they are not the causative agent of tuberculous (TB) or leprosy, i.e.,

Indexed as

antimicrobial drug discoverycystic fibrosisMycobacterium abscessusnon-tuberculous mycobacteria

Identifiers

PMID30909391
PMCPMC6463083
OpenAlexW2912845399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.